Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tilray

What's Going On With Tilray Stock Today?

Tilray Brands, Inc. (NASDAQ:TLRY) shares gained ground on Thursday after the marijuana company’s medical division expanded its portfolio in Germany with three newly certified cannabis strains.

Benzinga

Tilray’s Stock Price Is Growing Like a Weed. Here’s Why, and What Comes Next.

With rescheduling on the table, here are two option trades to play the potential spike in TLRY stock.

Barchart

Jefferies Just Raised Its Tilray Stock Price Target 33%. Should You Buy TLRY Here?

Tilray stock extends gains as Jefferies raises its price target on the cannabis firm to $2. But caution is warranted as TLRY shares are already up some 300% versus their year-to-date low.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Tilray's High Hopes: The Catalyst Driving Cannabis Stocks

Tilray's stock rally is fueled by market anticipation of a U.S. cannabis rescheduling decision, a key catalyst for the entire cannabis sector's future.

MarketBeat

Is Tilray Stock a Buy, Sell, or Hold for August 2025?

With global ambitions expanding and potential cannabis reclassification, should investors brace for upside? Or prepare for another volatile season?

Barchart

Dear Tilray Stock Fans, Mark Your Calendars for September 21

Tilray says it requested an extension to regain compliance with minimum listing requirements of the Nasdaq Exchange. Here’s why TLRY shares are still not worth owning at current levels.

Barchart

Following Mixed Q4 Results, Tilray's Turnaround Strategy Is Put To The Test

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading lower Tuesday morning after the global cannabis and consumer goods company reported fourth-quarter revenue that fell short of analyst expectations. Here’s what investors need to know.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Palantir, The Trade Desk, Tilray, Sonnet Biotherapeutics, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks traded mostly flat on Monday as investors reacted to President Donald Trump’s announcement of a 30% tariff on all imports from the EU and Mexico, effective August 1. Inflation worries ahead of Tuesday's CPI data also weighed on sentiment. By the close, the Dow rose 0.2% to 44,459.65,…

Benzinga

Tilray Shares Blazing: What's Behind the 55% Rally This Month?

Tilray's recent 55% rally may draw investor attention, but do the potential benefits outweigh the continued risks of this cannabis leader?

MarketBeat

Tilray Brands Stock Is Climbing Monday: What's Driving The Action?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading higher Monday morning, building on a recent rally fueled by heavy trading volume and company announcements. The cannabis giant’s stock has been a focal point for investors in recent sessions, driven by a combination of high short interest and positive industry news.

Benzinga

What's Going On With Tilray Brands Stock?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are surging higher Wednesday, extending a recent rally on heavy trading volume. Here’s what investors need to know.

Benzinga

Tilray (TLRY) Stock Surges On Heavy Volume: What Investors Should Know

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading sharply higher Tuesday afternoon, continuing a recent trend of investor interest across social media despite a lack of company-specific news for the session. Here’s what investors need to know.

Benzinga

What's Going On With Tilray Brands Stock Today?

Tilray Brands Inc (NASDAQ:TLRY) stock is trending across social media Thursday, despite a lack of fresh company-specific news for the session. The cannabis and consumer brands company made several strategic moves in June that could be fueling the current interest.

Benzinga

How I'm Trading 2025's Biggest Winners And Losers

I just wrapped up a deep dive into what I'm calling the "real report card" for 2025 so far…and the results might surprise you.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Seeking Stability? These 3 Stocks Offer Strong Potential

Consumer staples companies may offer some protection against volatility during times of tariff uncertainty; these stocks could be a defensive play.

Benzinga

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand

Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.

Benzinga

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow

Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic.

Barchart

Is Tilray Stock a Buy on Positive Cannabis Data?

Tilray reported a positive update for its chemo-related drug.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

1 Cannabis Stock I Would Buy, and One I Would Avoid

The cannabis industry is rapidly growing, but will Canadian players be able to keep up?

Barchart

Cresco vs. Tilray: Which Cannabis Stock Is a Better Buy?

Despite lingering regulatory challenges, the cannabis market is well-positioned for a steady expansion. Penny stock Cresco's solid financials and growth potential have won over analysts, while Tilray failed to impress with last quarter’s record revenue.

Barchart

2 Growth Stocks With 32% to 77% Upside in 2024

While AI stocks are the center of attention right now, many other growth stocks in various industries are going unnoticed. These stocks may benefit investors in the long run.

Investors Business Daily

Canopy Growth Stock Spikes, Weed Stocks Still Trade Higher Days After VP Harris Comments

Canopy Growth stock led weed stocks higher early Wednesday. Shares continue rallying on Vice President Kamala Harris' call to reclassify marijuana.

StockNews.com

Bullish or Bearish: 3 Pharma Options

The pharmaceutical industry’s robust outlook is driven by high healthcare spending globally, consistent R&D efforts, and the rapid adoption of advanced digital technologies. So, let’s analyze if investors should adopt a bullish or bearish stance on pharma stocks such as Tilray Brands (TLRY), CytomX Therapeutics (CTMX), and Wave Life Sciences…

Benzinga

Key Cannabis Exec Changes Investors Should Know About: ScottsMiracle Gro, Tilray, Metrc, & Willow Industries

ScottsMiracle-Gro Nominates Edith Avilés To Board Of Directors

Benzinga

Jim Cramer Is Bullish On Cannabis Stocks Ahead Of Midterm Elections: 'I Say Buy Tilray'

Mad Money host Jim Cramer said last week during a Lightning Round segment that now is a good time to invest in Tilray.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.